Antimicrobial makers may need Centre's nod before seeking licences
New Delhi, Nov. 20 -- The Union health ministry has proposed an amendment to the New Drugs and Clinical Trials Rules, 2019, that would require manufacturers of antimicrobials to obtain central permission before they can apply to a state for a manufacturing licence.
The draft notification dated November 6 proposes to include antimicrobials in the definition of "new drug" under the rules, the ministry said in a statement on Thursday. Manufacturers would then need permission from the Central Licensing Authority (CLA) before applying for a manufacturing licence from the state licensing authority (SLA) concerned. "This is expected to strengthen central regulatory oversight and help ensure the quality, safety and efficacy of antimicrobial product...
To read the full article or to get the complete feed from this publication, please
Contact Us.